Indian pharmaceuticals major Cipla Ltd on Friday said that its board had approved a proposal to raise up to Rs3,000 crore through sale of equity shares or equity linked instruments, the company said in a stock exchange filing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
